Your browser doesn't support javascript.
loading
Initial hydroxychloroquine monotherapy in systemic lupus erythematosus: report of three cases.
Ichikawa, Kento; Kirino, Yohei; Kunishita, Yosuke; Kishimoto, Daiga; Takase-Minegishi, Kaoru; Yoshimi, Ryusuke; Nakajima, Hideaki.
Afiliação
  • Ichikawa K; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kirino Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kunishita Y; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kishimoto D; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Takase-Minegishi K; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Yoshimi R; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Nakajima H; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Mod Rheumatol Case Rep ; 5(2): 259-264, 2021 07.
Article em En | MEDLINE | ID: mdl-33533686

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidroxicloroquina / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidroxicloroquina / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2021 Tipo de documento: Article